Prospective phase II study of: neo-adjuvant doxorubicin followed sequentially by cisplatin/docetaxel in locally advanced breast cancer

被引：0
|
作者：
不详
机构：
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [21] Phase II neoadjuvant docetaxel/cisplatin followed by concurrent cisplatin/radiotherapy for locally advanced nasopharyngeal cancer
    Kandil, M. S.
    Alnasser, H. S.
    Bandey, S. A.
    Almutairy, A. S.
    Ammar, F. A.
    Saadeddin, A. A.
    Murshid, E. M.
    Asiri, M. A.
    Zahrani, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Neo-adjuvant chemotherapy with weekly docetaxel (taxotere) in poor prognosis locally-advanced breast cancer (LABC).
    Bines, J
    Vinholes, J
    Del Giglio, A
    Vasconcelos, A
    Cabral, C
    Gusmao, C
    Martins, RG
    Carmo, PAO
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S54 - S54
  • [23] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [24] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [25] Neo-adjuvant Therapy in Locally Advanced Vulvar Cancer
    Kumari, Rashmi
    Desai, Ava D.
    Patel, Bijal M.
    Parekh, Chetna D.
    Patel, Shilpa M.
    Mankad, Meeta
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 14 (03)
  • [26] Neo-adjuvant Therapy in Locally Advanced Vulvar Cancer
    Rashmi Kumari
    Ava D. Desai
    Bijal M. Patel
    Chetna D. Parekh
    Shilpa M. Patel
    Meeta Mankad
    Indian Journal of Gynecologic Oncology, 2016, 14 (3)
  • [27] A phase II trial of neo-adjuvant docetaxel (D) and estramustine (E) in patients with high risk/locally advanced prostate cancer.
    Baggstrom, MQ
    Rosenman, J
    Pruthi, R
    Whang, Y
    Goyal, L
    Grigson, G
    Godley, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 444S - 444S
  • [28] Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide plus /- Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)
    Tuxen, M. K.
    Cold, S.
    Tange, U. B.
    Soendergaard, S. B.
    Nielsen, D. L.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S173 - S173
  • [29] Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer
    Grazia, Artioli
    Simone, Mocellin
    Lucia, Borgato
    Alessandro, Cappetta
    Fernando, Bozza
    Giorgio, Zavagno
    Stefania, Zovato
    Alberto, Marchet
    Davide, Pastorelli
    ANTICANCER RESEARCH, 2010, 30 (09) : 3817 - 3821
  • [30] Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study
    Ferrandina, Gabriella
    Palluzzi, Eleonora
    Gallotta, Valerio
    Gambacorta, Maria Antonietta
    Autorino, Rosa
    Turco, Luigi Carlo
    Macchia, Gabriella
    Cosentino, Francesco
    Gui, Benedetta
    Mattoli, Maria Vittoria
    Ronzino, Graziana
    Valentini, Vincenzo
    Scambia, Giovanni
    EJSO, 2018, 44 (07): : 1062 - 1068
12345